Skip Content
You are currently on the new version of our website. Access the old version .
  • Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Current Oncology, Volume 23, Issue 6

2016 December - 25 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (25)

  • Editorial
  • Open Access
654 Views
3 Pages

1 December 2016

The updated guideline on lung cancer screening released in March 2016 by the Canadian Task Force on Preventive Health Care recommends screening for people at high risk for lung cancer.[...]

  • Article
  • Open Access
17 Citations
1,125 Views
8 Pages

The Experiences of Cancer Survivors While Transitioning from Tertiary to Primary Care

  • B.B. Franco,
  • L. Dharmakulaseelan,
  • A. McAndrew,
  • S. Bae,
  • M.C. Cheung and
  • S. Singh

1 December 2016

Purpose: In current fiscally constrained health care systems, the transition of cancer survivors to primary care from tertiary care settings is becoming more common and necessary. The purpose of our study was to explore the experiences of survivors w...

  • Article
  • Open Access
26 Citations
1,300 Views
5 Pages

1 December 2016

Introduction: Despite adjuvant systemic therapy in patients with completely resected non-small-cell lung cancer (NSCLC), many will subsequently relapse. We investigated treatment choices at relapse and assessed the effect of palliative platinum doubl...

  • Article
  • Open Access
1,001 Views
7 Pages

The Risk of Colorectal Cancer Is Not Increased after a Diagnosis of Urothelial Cancer: A Population-Based Study

  • C.H. Harlos,
  • H. Singh,
  • Z. Nugent,
  • A. Demers,
  • S.M. Mahmud and
  • P.M. Czaykowski

1 December 2016

Background The data about whether patients with a prior urothelial cancer (UCa) are at increased risk of colorectal cancer (CRC) are conflicting. We used a competing risks analysis to determine the risk of CRC after UCa. Methods Historical cohorts we...

  • Review
  • Open Access
62 Citations
4,404 Views
9 Pages

1 December 2016

“Cannabinoid” is the collective term for a group of chemical compounds that either are derived from the Cannabis plant, are synthetic analogues, or occur endogenously. Although cannabinoids interact mostly at the level of the currently recognized can...

  • Review
  • Open Access
12 Citations
1,156 Views
11 Pages

Emerging Therapies for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • D. MacDonald,
  • A. Prica,
  • S. Assouline,
  • A. Christofides,
  • T. Lawrence and
  • L.H. Sehn

1 December 2016

With no treatment standard having been established for relapsed and refractory follicular lymphoma, a number of therapeutic approaches are used in Canada. In patients who relapse early or who eventually become resistant to subsequent treatment, progn...

  • Article
  • Open Access
29 Citations
1,233 Views
7 Pages

1 December 2016

Background Updated practice guidelines on adjuvant chemotherapy for completely resected colon cancer are lacking. In 2008, Cancer Care Ontario’s Program in Evidence-Based Care developed a guideline on adjuvant therapy for stages ii and iii colon canc...

  • Article
  • Open Access
4 Citations
903 Views
10 Pages

Report from the 17th Annual Western Canadian Gastrointestinal Cancer Consensus Conference; Edmonton, Alberta; 11–12 September 2015

  • K.E. Mulder,
  • S. Ahmed,
  • J.D. Davies,
  • C.M. Doll,
  • S. Dowden,
  • S. Gill,
  • V. Gordon,
  • P. Hebbard,
  • H. Lim and
  • R. Wong
  • + 3 authors

1 December 2016

The 17th annual Western Canadian Gastrointestinal Cancer Consensus Conference (wcgccc) was held in Edmonton, Alberta, 11–12 September 2015. The wcgccc is an interactive multidisciplinary conference attended by health care professionals from across We...

  • Article
  • Open Access
8 Citations
979 Views
8 Pages

1 December 2016

Background: Participant selection for first-in-human (FIH) trials involves complex decisions. The trial design makes it unlikely that participants will receive clinically relevant therapeutic benefit, but they are likely to experience risks of variou...

  • Article
  • Open Access
8 Citations
1,084 Views
8 Pages

1 December 2016

Background: After treatment for early-stage breast cancer (bca), annual surveillance mammography (asm) is recommended based on the assumption that early detection of an invasive ipsilateral breast tumour recurrence or subsequent invasive contralatera...

  • Article
  • Open Access
42 Citations
1,579 Views
10 Pages

Socioeconomic Status and Lifestyle Behaviours in Cancer Survivors: Smoking and Physical Activity

  • H. Naik,
  • X. Qiu,
  • M.C. Brown,
  • L. Eng,
  • D. Pringle,
  • M. Mahler,
  • H. Hon,
  • K. Tiessen,
  • H. Thai and
  • G. Liu
  • + 10 authors

1 December 2016

Purpose: Smoking cessation and increased physical activity (PA) have been linked to better outcomes in cancer survivors. We assessed whether socioeconomic factors influence changes in those behaviours after a cancer diagnosis. Methods: As part of a c...

  • Article
  • Open Access
18 Citations
1,238 Views
7 Pages

1 December 2016

Background: There is wide variation in the application of adjuvant chemotherapy in early-stage epithelial ovarian cancer. Our aim was to assess differences in health-related quality of life (HRQOL) between patients with early-stage ovarian cancer who...

  • Article
  • Open Access
17 Citations
1,744 Views
8 Pages

Burden of Illness for Metastatic Melanoma in Canada, 2011–2013

  • D.S. Ernst,
  • T. Petrella,
  • A.M. Joshua,
  • A. Hamou,
  • M. Thabane,
  • S. Vantyghem and
  • F. Gwadry-Sridhar

1 December 2016

Background: Detailed epidemiology for patients with advanced metastatic melanoma in Canada is not well characterized. We conducted an analysis of patients with this disease in the province of Ontario, with the aim being to study the presentation, dis...

  • Article
  • Open Access
8 Citations
1,388 Views
5 Pages

Personalized Oncogenomics in the Management of Gastrointestinal Carcinomas—Early Experiences from a Pilot Study

  • B.S. Sheffield,
  • B. Tessier-Cloutier,
  • H. Li-Chang,
  • Y. Shen,
  • E. Pleasance,
  • K. Kasaian,
  • Y. Li,
  • S.J.M. Jones,
  • H.J. Lim and
  • D.F. Schaeffer
  • + 5 authors

1 December 2016

Background: Gastrointestinal carcinomas are genomically complex cancers that are lethal in the metastatic setting. Whole-genome and transcriptome sequencing allow for the simultaneous characterization of multiple oncogenic pathways. Methods: We repor...

  • Article
  • Open Access
16 Citations
1,672 Views
7 Pages

1 December 2016

Background: Scalp cooling has been used since the 1970s to prevent chemotherapy-induced alopecia, one of the most common and psychologically troubling side effects of chemotherapy. Currently available scalp cOf the 55 patients, 78% underwent scalp co...

  • Article
  • Open Access
15 Citations
976 Views
6 Pages

A Retrospective Analysis of the Role of Proton Pump Inhibitors in Colorectal Cancer Disease Survival

  • C. Graham,
  • C. Orr,
  • C.S. Bricks,
  • W.M. Hopman,
  • N. Hammad and
  • R. Ramjeesingh

1 December 2016

Background: Proton pump inhibitors (PPIS) are a commonly used medication. A limited number of studies have identified a weak-to-moderate association between PPI use and colorectal cancer (CRC) risk, but none to date have identified an effect of PPI u...

  • Article
  • Open Access
18 Citations
1,693 Views
9 Pages

Treatment Patterns and Survival in Patients with ALK-Positive Non-small-Cell Lung Cancer: A Canadian Retrospective Study

  • S. Kayaniyil,
  • M. Hurry,
  • J. Wilson,
  • P. Wheatley-Price,
  • B. Melosky,
  • J. Rothenstein,
  • V. Cohen,
  • C. Koch,
  • J. Zhang and
  • G. Liu
  • + 1 author

1 December 2016

Background Crizotinib was the first agent approved for the treatment of anaplastic lymphoma kinase (ALK)– positive (+) non-small-cell lung cancer (NSCLC), followed by ceritinib. However, patients eventually progress or develop resistance to crizotini...

  • Article
  • Open Access
7 Citations
1,068 Views
7 Pages

Risk Stratification, Treatment Selection, and Transplant Eligibility in Multiple Myeloma: A Qualitative Study of the Perspectives and Self-Reported Practices of Oncologists

  • T.W. LeBlanc,
  • A. Howson,
  • W. Turell,
  • P. Sheldon,
  • S.C. Locke,
  • S.A. Tuchman,
  • C. Gasparetto,
  • S. Kaura,
  • Z.M. Khan and
  • A.P. Abernethy

1 December 2016

Background Since the early 2000s, treatment options for multiple myeloma have rapidly expanded, adding significant complexity to the management of this disease. To our knowledge, no systematic qualitative research on clinical decision-making in multi...

  • Article
  • Open Access
7 Citations
1,122 Views
10 Pages

Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016

  • D. Bossé,
  • T. Ng,
  • C. Ahmad,
  • A. Alfakeeh,
  • I. Alruzug,
  • J. Biagi,
  • J. Brierley,
  • P. Chaudhury,
  • S. Cleary and
  • T. Asmis
  • + 25 authors

1 December 2016

The annual Eastern Canadian Gastrointestinal Cancer Consensus Conference 2016 was held in Montreal, Quebec, 5–7 February. Experts in radiation oncology, medical oncology, surgical oncology, and infectious diseases involved in the management of patien...

  • Guidelines
  • Open Access
36 Citations
2,141 Views
11 Pages

Recommendations on Breast Cancer Screening and Prevention in the Context of Implementing Risk Stratification: Impending Changes to Current Policies

  • J. Gagnon,
  • E. Lévesque,
  • F. Borduas,
  • J. Chiquette,
  • C. Diorio,
  • N. Duchesne,
  • M. Dumais,
  • L. Eloy,
  • W. Foulkes and
  • J. Simard
  • + 11 authors

1 December 2016

In recent years, risk stratification has sparked interest as an innovative approach to disease screening and prevention. The approach effectively personalizes individual risk, opening the way to screening and prevention interventions that are adapted...

  • Article
  • Open Access
4 Citations
892 Views
4 Pages

Cancer Referral and Treatment Activity 2010–2015: A Population-Based Study from Vancouver Island

  • P. Savage,
  • C. Holloway,
  • G. Lindsay,
  • K. Shubrook,
  • C. Jones,
  • M. Fung,
  • K. Schaff,
  • H. Anderson,
  • K. Nystedt and
  • J. Rauw

1 December 2016

Introduction The years since 2005 have seen major changes in cancer treatment and significant increases in the number of anticancer drugs available. However, there are relatively few published data to reflect how those changes are affecting the activ...

  • Article
  • Open Access
10 Citations
1,273 Views
17 Pages

1 December 2016

Background Primary cutaneous plasmacytoma (pcp) is a rare disease, with few studies to guide therapy. Our primary study objective was to define treatments used for pcp; a secondary objective was to describe outcomes of patients, including disease rec...

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Curr. Oncol. - ISSN 1718-7729